The global cord blood banking services market is anticipated to expand significantly, reaching USD 49.85 billion by 2031 from USD 33.85 billion in 2025, according to analysis by Mordor Intelligence. This expansion represents a compound annual growth rate of 6.84% over the forecast period, reflecting sustained demand for cellular preservation and therapeutic applications.
The market expansion is underpinned by multiple factors, including heightened awareness regarding stem cell therapies and continued advancements in regenerative medicine technologies. Clinical applications have broadened considerably, with cord blood-derived therapies increasingly utilized in the treatment of hematological and genetic disorders. These developments have expanded the addressable market beyond traditional banking services into broader therapeutic domains.
Geographically, North America maintains dominance with a 39.54% market share, though the Asia-Pacific region is emerging as a significant growth driver. The regional variation reflects differences in healthcare infrastructure, regulatory environments, and adoption rates of regenerative medicine technologies across key markets. Industry participants are positioning themselves to capitalize on both established and developing markets as clinical validation and consumer demand continue to evolve.